Risk factors for the development of cystic fibrosis related liver disease
Version of Record online: 30 DEC 2003
Copyright © 2003 American Association for the Study of Liver Diseases
Volume 38, Issue 3, pages 775–776, September 2003
How to Cite
Slieker, M. G., Deckers-Kocken, J. M., Uiterwaal, C. S. P. M., van der Ent, C. K. and Houwen, R. H. J. (2003), Risk factors for the development of cystic fibrosis related liver disease. Hepatology, 38: 775–776. doi: 10.1053/jhep.2003.50403
- Issue online: 30 DEC 2003
- Version of Record online: 30 DEC 2003
- 5Regular screening for serum liver enzymes and appropriate early therapy with ursodeoxycholic acid (UDCA) delays severe liver disease in CF [Abstract]. Pediatr Pulmonol 2001; 22(Suppl):340–341., , , .
- 10The association between liver disease and mutations of the cystic fibrosis gene [Abstract]. Pediatr Pulmonol 1992; 8(Suppl):244., , , , .